Who owns HALOZYME THERAPEUTICS INC NOTE 1.000 8/1?
- CUSIP Number: 40637haf6
Tip: Access positions for across all investors
Analyze quarterly positions in Halozyme Therapeutics Inc Note 1.000 8/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Halozyme Therapeutics Inc Note 1.000 8/1 stock
Who bought or sold HALOZYME THERAPEUTICS INC NOTE 1.000 8/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Millennium Management | 89M | $125M | 72% | Sep 2025 |
|
| LMR Partners | 50M | $71M | 100% | Sep 2025 |
|
| Calamos Advisors | 40M | $56M | 0% | Sep 2025 |
|
| Camden Asset Management | 35M | $50B | -48% | Sep 2025 |
|
| Balyasny Asset Management | 35M | $49M | 100% | Sep 2025 |
|
| DLD Asset Management | 30M | $42M | 140% | Sep 2025 |
|
| Point72 Asset Management | 29M | $41M | 100% | Sep 2025 |
|
| Davidson Kempner Capital Management | 25M | $35M | 25% | Sep 2025 |
|
| Jpmorgan Chase & Co | 22M | $31M | 249% | Sep 2025 |
|
| Jain Global | 20M | $28M | 167% | Sep 2025 |
|
| Nuveen | 18M | $25M | 100% | Sep 2025 |
|
| Lazard Asset Management | 17M | $236k | -53% | Sep 2025 |
|
| State Street Corporation | 14M | $20M | 4% | Sep 2025 |
|
| Absolute Investment Advisers | 14M | $20M | 0% | Sep 2025 |
|
| Citadel Advisors | 14M | $20M | -29% | Sep 2025 |
|
| Linden Advisors | 13M | $18M | 100% | Sep 2025 |
|
| Wells Fargo & Company | 12M | $17M | -15% | Sep 2025 |
|
| Tenor Capital Management | 11M | $15M | 100% | Sep 2025 |
|
| Morgan Stanley | 10M | $12M | 100% | Jun 2025 |
|
| FMR | 9.5M | $13M | -12% | Sep 2025 |
|
| Franklin Resources | 8.9M | $13M | 2% | Sep 2025 |
|
| Advent Capital Management | 8.4M | $12M | -4% | Sep 2025 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 8.1M | $11M | 0% | Sep 2025 |
|
| Mirabaud Asset Management | 7.8M | $8.9B | 100% | Jun 2025 |
|
| Deutsche Bank Aktiengesellschaft | 7.3M | $10M | 26% | Sep 2025 |
|
| UBS O'Connor | 7.0M | $9.9M | -69% | Sep 2025 |
|
| BlackRock | 7.0M | $9.8M | -60% | Sep 2025 |
|
| Ofi Invest Asset Management | 6.8M | $8.2M | -8% | Sep 2025 |
|
| SSI Investment Management | 6.1M | $8.6M | -1% | Sep 2025 |
|
| Bank Of Montreal | 6.0M | $6.8M | 100% | Jun 2025 |
|
| Warberg Asset Management | 5.1M | $7.2M | 2% | Sep 2025 |
|
| Leucadia National Corporation | 5.1M | $7.2M | 52% | Sep 2025 |
|
| Susquehanna Advisors Group | 5.0M | $70k | 100% | Sep 2025 |
|
| Walleye Trading Advisors | 4.5M | $6.3M | 0% | Sep 2025 |
|
| Union Bancaire Privee, UBP SA | 4.4M | $5.2M | -3% | Sep 2025 |
|
| Invesco | 4.0M | $5.6M | -38% | Sep 2025 |
|
| State of Wisconsin Investment Board | 3.0M | $4.2M | 100% | Sep 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 2.6M | $3.6M | -35% | Sep 2025 |
|
| RWC Asset Management | 2.3M | $3.3M | -27% | Sep 2025 |
|
| Sonora Investment Management Group | 2.2M | $3.2M | -2% | Sep 2025 |
|
| Capital World Investors | 2.2M | $3.0M | 100% | Sep 2025 |
|
| Man Group | 2.0M | $2.9M | -4% | Sep 2025 |
|
| Toronto-Dominion Bank | 1.7M | $2.4M | -35% | Sep 2025 |
|
| Agf Management | 1.5M | $2.1M | -25% | Sep 2025 |
|
| Barclays | 1.3M | $1.8M | 374% | Sep 2025 |
|
| Prospector Partners | 1.2M | $1.7M | 0% | Sep 2025 |
|
| Palisade Capital Management | 1.1M | $1.5M | -32% | Sep 2025 |
|
| Zurcher Kantonalbank | 1.0M | $1.4M | 0% | Sep 2025 |
|
| Westwood Holdings | 1.0M | $1.4M | -56% | Sep 2025 |
|
| Shenkman Capital Management | 900k | $1.3B | -79% | Sep 2025 |
|
| Quaero Capital | 800k | $911k | 0% | Jun 2025 |
|
| Dnca Finance | 630k | $887k | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 611k | $862k | -75% | Sep 2025 |
|
| Bank of New York Mellon | 500k | $703k | -41% | Sep 2025 |
|
| Jane Street | 425k | $603k | -15% | Sep 2025 |
|
| Royal Bank of Canada | 320k | $451k | -82% | Sep 2025 |
|
| Central Pacific Bank - Trust Division | 317k | $445k | 0% | Sep 2025 |
|
| Russell Investments | 232k | $327k | -29% | Sep 2025 |
|
| Flossbach Von Storch | 200k | $282k | -50% | Sep 2025 |
|
| Virtus ETF Advisers | 65k | $91k | 0% | Sep 2025 |
|
| Fifth Third Bancorp | 10k | $1.4M | 100% | Sep 2025 |
|
| Steward Partners Investment Advisory | 6.0k | $8.4k | 0% | Sep 2025 |
|
| Us Bancorp | 5.0k | $7.0k | 0% | Sep 2025 |
|
| Loomis, Sayles and | 3.6k | $262k | 0% | Sep 2025 |
|
| Boussard & Gavaudan Investment Management | 2.1k | $3.0M | 100% | Sep 2025 |
|
| Alken Asset Management | 2.0k | $2.9M | -23% | Sep 2025 |
|
| UBS Group | 1.3k | $1.9k | 99% | Sep 2025 |
|
| Erste Asset Management GmbH | 0 | $0 | -100% | Sep 2025 |
|
Who sold out of Halozyme Therapeutics Inc Note 1.000 8/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| MacKay Shields | Jun 2025 | 44M | $50M |
| Wolverine Asset Management | Jun 2025 | 34M | $39M |
| M&G | Jun 2025 | 27M | $98M |
| CSS | Jun 2025 | 10M | $12M |
| Healthcare Of Ontario Pension Plan Trust Fund | Jun 2025 | 9.0M | $10M |
| Two Sigma Investments | Jun 2025 | 9.0M | $10M |
| DeepCurrents Investment Group | Jun 2025 | 7.8M | $8.8M |
| Ameriprise Financial | Jun 2025 | 5.0M | $5.7M |
| Amundi | Jun 2025 | 3.5M | $4.1M |
| Kohlberg Kravis Roberts & Co | Jun 2025 | 3.5M | $4.0B |
| Wellesley Investment Advisors | Jun 2025 | 3.3M | $3.7B |
| Macquarie Group | Jun 2025 | 1.7M | $1.9M |
| Sei Investments | Jun 2025 | 322k | $367k |
| Teton Advisors | Mar 2025 | 300k | $385k |
| Ubs Global Asset Management Americas | Jun 2025 | 200k | $228k |
| KBC Group NV | Mar 2025 | 200k | $257k |
| Abn Amro Investment Solutions | Mar 2025 | 200k | $257k |
| Oppenheimer Asset Management | Jun 2025 | 163k | $186k |
| Stephens | Jun 2025 | 50k | $57k |
| Balboa Wealth Partners | Jun 2025 | 26k | $30k |
| Nomura Holdings | Jun 2025 | 20k | $1.0M |